Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination

BackgroundPre-existing cross-reactive immunity among different coronaviruses, also termed immune imprinting, may have a comprehensive impact on subsequent SARS-CoV-2 infection and COVID-19 vaccination effectiveness. Here, we aim to explore the interplay between pre-existing seasonal coronaviruses (s...

Full description

Bibliographic Details
Main Authors: Di Yin, Zirong Han, Bing Lang, Yanjun Li, Guoqin Mai, Hongbiao Chen, Liqiang Feng, Yao-qing Chen, Huanle Luo, Yaming Xiong, Lin Jing, Xiangjun Du, Yuelong Shu, Caijun Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1195533/full
_version_ 1797741763078651904
author Di Yin
Di Yin
Zirong Han
Zirong Han
Bing Lang
Bing Lang
Yanjun Li
Guoqin Mai
Guoqin Mai
Hongbiao Chen
Liqiang Feng
Yao-qing Chen
Yao-qing Chen
Huanle Luo
Huanle Luo
Yaming Xiong
Lin Jing
Xiangjun Du
Xiangjun Du
Xiangjun Du
Yuelong Shu
Yuelong Shu
Yuelong Shu
Caijun Sun
Caijun Sun
Caijun Sun
author_facet Di Yin
Di Yin
Zirong Han
Zirong Han
Bing Lang
Bing Lang
Yanjun Li
Guoqin Mai
Guoqin Mai
Hongbiao Chen
Liqiang Feng
Yao-qing Chen
Yao-qing Chen
Huanle Luo
Huanle Luo
Yaming Xiong
Lin Jing
Xiangjun Du
Xiangjun Du
Xiangjun Du
Yuelong Shu
Yuelong Shu
Yuelong Shu
Caijun Sun
Caijun Sun
Caijun Sun
author_sort Di Yin
collection DOAJ
description BackgroundPre-existing cross-reactive immunity among different coronaviruses, also termed immune imprinting, may have a comprehensive impact on subsequent SARS-CoV-2 infection and COVID-19 vaccination effectiveness. Here, we aim to explore the interplay between pre-existing seasonal coronaviruses (sCoVs) antibodies and the humoral immunity induced by COVID-19 vaccination.MethodsWe first collected serum samples from healthy donors prior to COVID-19 pandemic and individuals who had received COVID-19 vaccination post-pandemic in China, and the levels of IgG antibodies against sCoVs and SARS-CoV-2 were detected by ELISA. Wilcoxon rank sum test and chi-square test were used to compare the difference in magnitude and seropositivity rate between two groups. Then, we recruited a longitudinal cohort to collect serum samples before and after COVID-19 vaccination. The levels of IgG antibodies against SARS-CoV-2 S, S1, S2 and N antigen were monitored. Association between pre-existing sCoVs antibody and COVID-19 vaccination-induced antibodies were analyzed by Spearman rank correlation.Results96.0% samples (339/353) showed the presence of IgG antibodies against at least one subtype of sCoVs. 229E and OC43 exhibited the highest seroprevalence rates at 78.5% and 72.0%, respectively, followed by NL63 (60.9%) and HKU1 (52.4%). The levels of IgG antibodies against two β coronaviruses (OC43 and HKU1) were significantly higher in these donors who had inoculated with COVID-19 vaccines compared to pre-pandemic healthy donors. However, we found that COVID-19 vaccine-induced antibody levels were not significant different between two groups with high levelor low level of pre-existing sCoVs antibody among the longitudinal cohort.ConclusionWe found a high prevalence of antibodies against sCoVs in Chinese population. The immune imprinting by sCoVs could be reactivated by COVID-19 vaccination, but it did not appear to be a major factor affecting the immunogenicity of COVID-19 vaccine. These findings will provide insights into understanding the impact of immune imprinting on subsequent multiple shots of COVID-19 vaccines.
first_indexed 2024-03-12T14:31:20Z
format Article
id doaj.art-5f7f1f97777442b38f34b0c3bdd5eae9
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T14:31:20Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5f7f1f97777442b38f34b0c3bdd5eae92023-08-17T12:42:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-08-011410.3389/fimmu.2023.11955331195533Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccinationDi Yin0Di Yin1Zirong Han2Zirong Han3Bing Lang4Bing Lang5Yanjun Li6Guoqin Mai7Guoqin Mai8Hongbiao Chen9Liqiang Feng10Yao-qing Chen11Yao-qing Chen12Huanle Luo13Huanle Luo14Yaming Xiong15Lin Jing16Xiangjun Du17Xiangjun Du18Xiangjun Du19Yuelong Shu20Yuelong Shu21Yuelong Shu22Caijun Sun23Caijun Sun24Caijun Sun25School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaEmergency Manage Department, Foshan, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaDepartment of Epidemiology and Infectious Disease Control, Shenzhen, ChinaState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaInstitute of Clinical Medicine, First People's Hospital of Foshan, Foshan, ChinaInstitute of Clinical Medicine, First People's Hospital of Foshan, Foshan, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaKey Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaNational Health Commission of the People's Republic of China (NHC) Key Laboratory of System Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, ChinaKey Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, ChinaBackgroundPre-existing cross-reactive immunity among different coronaviruses, also termed immune imprinting, may have a comprehensive impact on subsequent SARS-CoV-2 infection and COVID-19 vaccination effectiveness. Here, we aim to explore the interplay between pre-existing seasonal coronaviruses (sCoVs) antibodies and the humoral immunity induced by COVID-19 vaccination.MethodsWe first collected serum samples from healthy donors prior to COVID-19 pandemic and individuals who had received COVID-19 vaccination post-pandemic in China, and the levels of IgG antibodies against sCoVs and SARS-CoV-2 were detected by ELISA. Wilcoxon rank sum test and chi-square test were used to compare the difference in magnitude and seropositivity rate between two groups. Then, we recruited a longitudinal cohort to collect serum samples before and after COVID-19 vaccination. The levels of IgG antibodies against SARS-CoV-2 S, S1, S2 and N antigen were monitored. Association between pre-existing sCoVs antibody and COVID-19 vaccination-induced antibodies were analyzed by Spearman rank correlation.Results96.0% samples (339/353) showed the presence of IgG antibodies against at least one subtype of sCoVs. 229E and OC43 exhibited the highest seroprevalence rates at 78.5% and 72.0%, respectively, followed by NL63 (60.9%) and HKU1 (52.4%). The levels of IgG antibodies against two β coronaviruses (OC43 and HKU1) were significantly higher in these donors who had inoculated with COVID-19 vaccines compared to pre-pandemic healthy donors. However, we found that COVID-19 vaccine-induced antibody levels were not significant different between two groups with high levelor low level of pre-existing sCoVs antibody among the longitudinal cohort.ConclusionWe found a high prevalence of antibodies against sCoVs in Chinese population. The immune imprinting by sCoVs could be reactivated by COVID-19 vaccination, but it did not appear to be a major factor affecting the immunogenicity of COVID-19 vaccine. These findings will provide insights into understanding the impact of immune imprinting on subsequent multiple shots of COVID-19 vaccines.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1195533/fullSARS-CoV-2seasonal coronavirusimmune imprintingCOVID-19 vaccinationpre-existing immunity
spellingShingle Di Yin
Di Yin
Zirong Han
Zirong Han
Bing Lang
Bing Lang
Yanjun Li
Guoqin Mai
Guoqin Mai
Hongbiao Chen
Liqiang Feng
Yao-qing Chen
Yao-qing Chen
Huanle Luo
Huanle Luo
Yaming Xiong
Lin Jing
Xiangjun Du
Xiangjun Du
Xiangjun Du
Yuelong Shu
Yuelong Shu
Yuelong Shu
Caijun Sun
Caijun Sun
Caijun Sun
Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
Frontiers in Immunology
SARS-CoV-2
seasonal coronavirus
immune imprinting
COVID-19 vaccination
pre-existing immunity
title Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
title_full Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
title_fullStr Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
title_full_unstemmed Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
title_short Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
title_sort effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated covid 19 vaccination
topic SARS-CoV-2
seasonal coronavirus
immune imprinting
COVID-19 vaccination
pre-existing immunity
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1195533/full
work_keys_str_mv AT diyin effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT diyin effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT zironghan effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT zironghan effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT binglang effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT binglang effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT yanjunli effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT guoqinmai effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT guoqinmai effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT hongbiaochen effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT liqiangfeng effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT yaoqingchen effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT yaoqingchen effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT huanleluo effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT huanleluo effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT yamingxiong effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT linjing effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT xiangjundu effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT xiangjundu effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT xiangjundu effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT yuelongshu effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT yuelongshu effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT yuelongshu effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT caijunsun effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT caijunsun effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination
AT caijunsun effectofseasonalcoronavirusimmuneimprintingontheimmunogenicityofinactivatedcovid19vaccination